Phospho-Akt (Ser473) Recombinant Rabbit mAb (S-622-64)
AKT,V-AKT,AKT kinase-transforming protein,RAC-alpha serine/threonine-protein kinase,Protein kinase B (PKB),Protein kinase B alpha (PKB alpha),Proto-oncogene c-Akt,RAC-PK-alpha,PKB,RAC,AKT1
货号： S0B0611
- 价格： ￥600
- 规格：
- 数量：
大包装询价 产品介绍 评论(0)
别名
AKT,V-AKT,AKT kinase-transforming protein,RAC-alpha serine/threonine-protein kinase,Protein kinase B (PKB),Protein kinase B alpha (PKB alpha),Proto-oncogene c-Akt,RAC-PK-alpha,PKB,RAC,AKT1宿主来源
Rabbit抗原名称
Phospho-Akt (Ser473)免疫原
Synthetic Peptide细胞定位
Cell membrane, Cytoplasm, NucleusAccession
P31749克隆号
S-622-64抗体类型
Recombinant mAb抗体同种型
IgG应用
ICFCM, ICC, WB, IP反应种属 ?
Hu预测反应种属
(反应种属缩写表)Rt, Ms纯化方式
Protein A浓度
0.5 mg/ml标记
Unconjugated性状
Liquid缓冲体系
PBS, 40% Glycerol, 0.05% BSA, 0.03% Proclin 300储存条件
12 months from date of receipt / reconstitution, -20 °C as supplied
| 应用 | 稀释度 |
|---|---|
| WB | 1:1000 |
| ICC | 1:500 |
| ICFCM | 1:500 |
| Dot Blot | 1:1000 |
| IP | 1:50 |
Akt or Protein kinase B, is a serine/threonine kinase that plays an important role in regulating a number of cellular processes such as growth, metabolism and survival. The importance of the Akt pathway is highlighted by the mutation of various components of the pathway in human cancers such as the PTEN and PI3-kinase (P110α), which occur in more than 30% of human tumors. For Akt to achieve full activation, phosphorylation is needed at both serine 473 (ser473) of the hydrophobic tail and threonine 308 (thr308) of the activation motif, upon growth factor ligation to the receptor tyrosine kinases.
免疫印迹
WB result of Phospho-Akt (Ser473) Rabbit mAb
Primary antibody: Phospho-Akt (Ser473) Rabbit mAb at 1/1000 dilution
Lane 1: untreated Jurkat whole cell lysate 20 µg
Lane 2: Jurkat treated with 100 nM Calyculin A for 30 minutes whole cell lysate 20 µg
Secondary antibody: Goat Anti-rabbit IgG, (H+L), HRP conjugated at 1/10000 dilution
Predicted MW: 56 kDa
Observed MW: 60 kDa
流式分析
Flow cytometric analysis of 4% PFA fixed 90% methanol permeabilized Jurkat (Human T cell leukemia T lymphocyte) cells, treated with 100nM Calyculin A for 30 min (Red) or untreated (Green), labeling Phospho-Akt (Ser473) at 1/500 dilution (0.1 μg) compared with a rabbit monoclonal IgG isotype control (Black) and an unlabeled control (cells without incubation with primary antibody and secondary antibody) (Blue). Goat Anti - Rabbit IgG Alexa Fluor® 488 was used as the secondary antibody.
免疫沉淀
Phospho-Akt (Ser473) Rabbit mAb at 1/50 dilution (1 µg) immunoprecipitating Phospho-Akt (Ser473) in 0.4 mg Jurkat treated with 100 nM Calyculin A for 30 minutes whole cell lysate.
Western blot was performed on the immunoprecipitate using Phospho-Akt (Ser473) Rabbit mAb at 1/1000 dilution.
Secondary antibody (HRP) for IP was used at 1/1000 dilution.
Lane 1: Jurkat treated with 100 nM Calyculin A for 30 minutes whole cell lysate 20 µg (Input)
Lane 2: Phospho-Akt (Ser473) Rabbit mAb IP in Jurkat treated with 100 nM Calyculin A for 30 minutes whole cell lysate
Lane 3: Rabbit monoclonal IgG IP in Jurkat treated with 100 nM Calyculin A for 30 minutes whole cell lysate
Predicted MW: 56 kDa
Observed MW: 60 kDa
斑点杂交
Dot blot result of Phospho-Akt (Ser473) Rabbit mAb
Lane1: Phospho-Akt (Ser473) peptide
Lane2: Akt unmodified peptide Primary antibody: Phospho-Akt (Ser473) Rabbit mAb at 1/1000 dilution
Secondary antibody: Goat Anti-Rabbit IgG, (H+L), HRP conjugated at 1/10000 dilution
免疫细胞化学
ICC analysis of Jurkat cells treated with Calyculin A (100nM, 30 min) (top panel) and Jurkat cells untreated with Calyculin A (100nM, 30 min) (below panel). Anti-Phospho-Akt (Ser473) antibody was used at 1/500 dilution (Green) and incubated overnight at 4°C. Goat polyclonal Antibody to Rabbit IgG - H&L (Alexa Fluor® 488) was used as secondary antibody at 1/1000 dilution. The cells were fixed with 4% PFA and permeabilized with 0.1% PBS-Triton X-100. Nuclei were counterstained with DAPI (Blue). Counterstain with tubulin (Red).
评论(0)